RET et GDNF: Un récepteur orphelin trouve une famille nourricière

Medecine/Sciences

Volumn 12, Issue 12, 1996, Pages 1408-1413

  Chappuis, Sophie ^a   Geneste, Olivier ^a   Pasini, Andrea ^a   Lenoir, Gilbert ^a   Billaud, Marc ^a  

^a CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 5744220853     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/685     Document Type: Article

References (39)

1. Trupp M, Arenas E, Fainzilber M, Nilsson AS, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumäe U, Sariola H, Saarma M, Ibañez CF. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 1996; 381: 785-9.
2. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M, Sariola H, Pachnis V. GDNF signalling through the RET receptor tyrosine kinase. Nature 1996; 381: 789-93.
3. Sanchez MP, Silos-Santiago I, Frisén J, He B, Lira SA, Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996; 382: 70-3.
4. Pichel JG, Shen L, Sheng HZ, Granholm AC, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996; 382: 73-6.
5. Moore MW, Klein RD, Fariñas I, Sauer H, Armanini M, Phillips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996; 382: 76-9.
6. Treanor JJS, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature 1996; 382: 80-3.
7. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM. GDNF-induced activation of the RET protein tyrosine kinase is mediated by GDNFR-α, a novel receptor for GDNF. Cell 1996; 85: 1113-24.
8. Goodfellow PJ, Wells Jr SA. RET gene and its implication for cancer. J Natl Cancer Instit 1995; 87: 1515-23.
9. Pasini B, Ceccherini I, Romeo G. RET mutations in human disease. Trends Genet 1996; 12: 138-44.
10. Myers SM, Eng C, Ponder BAJ, Mulligan LM. Characterization of RET proto-oncogene 3′ splicing variants and polyadenylation sites: a novel C-terminus for RET. Oncogene 1995; 11: 2039-45.
11. Lyonnet S, Edery P, Attié T, Nihoul-Fékété C, Munnich A et le Consortium Français de la Maladie de Hirschsprung. Des mutations du proto-oncogène RET dans la maladie de Hirschprung: un gène à tout faire. médecine/sciences 1994; 4: 450-3.
12. Pachnis V, Mankoo B, Costantini F. Expression of the c-ret proto-oncogene during embryogenesis. Development 1993; 119: 1005-17.
13. Tsuzuki T, Takahashi M, Asai N, Iwashita T, Matsuyama M, Asai J. Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues. Oncogene 1995; 10: 191-8.
14. Schuchardt A, D'Agati V, Larsson-Blomberg L, Costantini F, Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994; 367: 380-3.
15. Durbec PL, Larsson-Blomberg LB, Schuchardt A, Costantini F, Pachnis V. Common origin and developmental dependence on c-ret of subsets of enteric and sympathetic neuroblasts. Development 1996; 122: 349-58.
16. Schuchardt A, D'Agati V, Pachnis V, Costantini F. Renal agenesis and hypodysplasia in ret-k- mutant mice result from defects in ureteric bud development. Development 1996; 122: 1919-29.
17. Lin LFH, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-2.
18. Kingsley DM. The TGF-β superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994; 8: 133-46.
19. McDonald NQ, Hendrickson WA. A structural superfamily of growth factors containing a cystine knot motif. Cell 1993; 73: 421-4.
20. Henderson CE, Phillips HS, Pollock RA, Davies AM, Lemeulle C, Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliastos VE, Rosenthal A. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 1994; 266: 1062-4.
21. Tomac A, Lindqvist E, Lin LFH, Ögren SO, Young D, Hoffer BJ, Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995; 373: 335-9.
22. Beck KD, Valverde J, Alexi T, Poulsen K, Moffat B, Vandlen RA, Rosenthal A, Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 1995; 373: 339-41.
23. Yan Q, Matheson C, Lopez OT. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 1995; 373: 341-4.
24. Oppenheim RW, Houenou LJ, Johnson JE, Lin LFH, Li L, Lo AC, Newsome AL, Prevette DM, Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature 1995; 373: 344-6.
25. Trupp M, Rydén M, Jörnvall H, Funakoshi H, Timmusk T, Arenas E, Ibañez CF. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 1995; 130: 137-48.
26. Arenas E, Trupp M, Åkerud P, Ibañez CF. GDNF prevents degeneration and promotes the phenotype of brain noradrenergic neurons in vivo. Neuron 1995; 15: 1465-73.
27. Buj-Bello A, Buchman VL, Horton A, Rosenthal A, Davies AM. GDNF is an age-specific survival factor for sensory and autonomic neurons. Neuron 1995; 15: 821-8.
28. Gash DM, Zhang Z, Ovadia A, Cass WA, Yi A, Simmerman L, Russell D, Martin D, Lapchak PA, Collins F, Hoffer BJ, Gerhardt GA. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996; 380: 252-5.
29. Heyd D, Aebischer P. Les facteurs neurotrophiques et leurs applications thérapeutiques potentielles. médecine/sciences 1996; 12: 299-302.
30. Suvanto P, Hiltunen JO, Arumäe U, Moshnyakov M, Sariola H, Sainio K, Saarma M. Localization of glial cell line-derived neurotrophic factor (GDNF) mRNA in embryonic rat by in situ hybridization. Eur J Neurosci 1996; 8: 816-22.
31. ten Dijke P, Miyazono K, Heldin CH. Signalling via hetero-oligomeric complexes of type I and type II serine/threonine kinase receptors. Curr Op Cell Biol 1996; 8: 139-45.
32. Dusanter-Fourt I, Mayeux P, Gisselbrecht S. Transduction du signal par les récepteurs de cytokines. médecine/sciences 1994; 10: 825-35.
33. Babinet C. Cre-LoxP et cellules souches embryonnaires. médecine/sciences 1995; 8: 1154-7.
34. Viville S. Recombinaison homologue: nouveaux vecteurs, nouvelles perspectives. médecine/sciences 1995; 11: 735-46.
35. Lamballe F. Les récepteurs tyrosine kinases Trk: récepteurs de forte affinite des neurotrophines. médecine/sciences 1995; 8: 1071-80.
36. Kotzbauer PT, Lampe PA, Johnson EM, Milbrandt J. Signalling in neuronal development, differentiation and degeneration, Keystone Symposia on Molecular and Cellular Biology. Taos, NM, 27 mars-2 avril 1996, p 136.
37. Poulsen KT, Armanini MP, Klein RD, Hynes MA, Phillips HS, Rosenthal A. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 1994; 13: 1245-52.
38. + toxicity. EMBO J 1995; 14: 736-42.
39. Attié T, Amiel J, Edery P, Lyonnet S. Endothélines et leurs récepteurs: de nouveaux acteurs du développement. médecine/sciences 1995; 11: 1172-5.